Pfizer Global Medical Grants Junior Investigator Global ATTR Amyloidosis Research ASPIRE

Well-being, Health and Biomedical Discovery


Academic Unit: inquire with unit

Memorial Deadline: Wednesday 23rd, March 2022

External Deadline: Monday 28th, March 2022


Request for Proposals (RFP)
Junior Investigator Global ATTR Amyloidosis Research ASPIRE

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the research program.

Geographic Scope: All countries except the United States
Clinical Area: ATTR amyloidosis
Link to full RFP: Junior Investigator Global ATTR Amyloidosis Research ASPIRE
Application Due Date: March 28, 2022
Specific Area of Interest: Pfizer is interested in supporting research proposals that advance our understanding of the epidemiology, basic science and early diagnosis and treatment of ATTR amyloidosis. Please note that applicants must be a junior investigator with a professional terminal degree (MD and/or PhD and/or PharmD or equivalent). Applicants must have obtained their terminal degree (finished all training) less than 10 years ago.

Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: January 28, 2022